Immune-related adverse events (irAEs) and the association with clinical outcomes in advanced genitourinary cancers treated with immunotherapy: A systematic review and meta-analysis.

被引：0
|
作者：
Zhang, Yaowen
Chen, Junru
Sun, Guangxi
Zhang, Xingming
Zeng, Hao
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, Inst Urol, Dept Urol, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183; 281-318-9082; 283-183-143-3231; 261-566-9718-9794; 261-492-3532-2370-7650-2700; 261-492-3532-2370-5109; 5; 4; 3; 2; 38116-38094-8; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.431
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：431 / 431
页数：1
相关论文
共 50 条
  • [1] ASSOCIATION BETWEEN IMMUNE-RELATED ADVERSE EVENTS AND CLINICAL OUTCOMES IN ADVANCED GENITOURINARY CANCERS TREATED WITH IMMUNOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Chen, Junru
    Zhang, Yaowen
    Ni, Yuchao
    Sun, Guangxi
    Zeng, Hao
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1023 - E1023
  • [2] Association between immune-related adverse events and clinical outcomes in advanced genitourinary cancers treated with immunotherapy: A systematic review and meta-analysis
    Chen, J.
    Zhang, Y.
    Ni, Y.
    Sun, G. S.
    Zeng, H.
    EUROPEAN UROLOGY, 2022, 81 : S598 - S598
  • [3] Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.
    Grizzi, Giulia
    Petrelli, Fausto
    Ghidini, Michele
    Ghidini, Antonio
    Ratti, Margherita
    Panni, Stefano
    Cabiddu, Mary
    Ghilardi, Mara
    Borgonovo, Karen
    Parati, Maria Chiara
    Barni, Sandro
    Tomasello, Gianluca
    Passalacqua, Rodolfo
    Berruti, Alfredo
    Brighenti, Matteo
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Immune-related adverse events and efficacy outcomes in patients treated with immunotherapy: A systematic review and meta-analysis
    Druyts, Eric
    Boye, Mark
    Agg, Himani
    Muehlenbein, Catherine
    Frederickson, Andrew
    Bayt, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [5] Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).
    Shabto, Julie M.
    Martini, Dylan J.
    Liu, Yuan
    Ravindranathan, Deepak
    Kline, Meredith R.
    Hitron, Elise
    Russler, Greta
    Caulfield, Sarah
    Kissick, Haydn
    Alemozaffar, Mehrdad
    Ogan, Kenneth
    Harris, Wayne
    Master, Viraj A.
    Carthon, Bradley Curtis
    Kucuk, Omer
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [6] The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
    Zhang, Yaowen
    Chen, Junru
    Liu, Haoyang
    Dai, Jindong
    Zhao, Junjie
    Zhu, Sha
    Zhang, Xingming
    Liang, Jiayu
    Hu, Xu
    Zhao, Jinge
    Liu, Zhenhua
    Shen, Pengfei
    Sun, Guangxi
    Zeng, Hao
    CANCER TREATMENT REVIEWS, 2024, 129
  • [7] Endocrine immune-related adverse events (irAEs) of combined immunotherapy in solid tumors: Systematic review and meta-analysis
    Tsoukalas, N. G.
    Tsitsimpis, A.
    Katsouda, A.
    Arvanitou, E.
    Bagos, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S845 - S845
  • [8] Association between the occurrence of immune-related adverse events and survival outcomes in patients with cancer treated with perioperative immune checkpoint inhibitors: A systematic review and meta-analysis.
    Komatsu, Taiga
    Chida, Kohei
    Horita, Nobuyuki
    Cortellini, Alessio
    Naqash, Abdul Rafeh
    Fujiwara, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 39 - 39
  • [9] Sarcopenia as biomarker for immunotherapy outcomes and immune-related adverse events - a systematic review and meta-analysis
    Guenther, S.
    Trinkner, P.
    von Bergwelt, M.
    dos Santos, Cordas D.
    Theurich, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 228 - 228
  • [10] SARCOPENIA AS BIOMARKER FOR IMMUNOTHERAPY OUTCOMES AND IMMUNE-RELATED ADVERSE EVENTS - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Guenther, S.
    Trinkner, P.
    von Bergwelt, M.
    dos Santos, D. Cordas
    Theurich, S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A7 - A7
12345